NeuroSense Therapeutics (NRSNW) Competitors

$0.12
-0.02 (-14.29%)
(As of 05/17/2024 ET)

NRSNW vs. ATNFW, SXTPW, DRTSW, APLMW, ARTLW, BCDAW, BCTXW, CDIOW, CTCXW, and SAVAW

Should you be buying NeuroSense Therapeutics stock or one of its competitors? The main competitors of NeuroSense Therapeutics include 180 Life Sciences (ATNFW), 60 Degrees Pharmaceuticals (SXTPW), Alpha Tau Medical (DRTSW), Apollomics (APLMW), Artelo Biosciences (ARTLW), BioCardia (BCDAW), BriaCell Therapeutics (BCTXW), Cardio Diagnostics (CDIOW), Carmell (CTCXW), and Cassava Sciences (SAVAW). These companies are all part of the "biotechnology" industry.

NeuroSense Therapeutics vs.

180 Life Sciences (NASDAQ:ATNFW) and NeuroSense Therapeutics (NASDAQ:NRSNW) are both medical companies, but which is the better business? We will contrast the two businesses based on the strength of their risk, media sentiment, profitability, analyst recommendations, institutional ownership, earnings, valuation, dividends and community ranking.

In the previous week, 180 Life Sciences had 1 more articles in the media than NeuroSense Therapeutics. MarketBeat recorded 1 mentions for 180 Life Sciences and 0 mentions for NeuroSense Therapeutics. NeuroSense Therapeutics' average media sentiment score of 0.93 beat 180 Life Sciences' score of 0.00 indicating that 180 Life Sciences is being referred to more favorably in the media.

Company Overall Sentiment
180 Life Sciences Positive
NeuroSense Therapeutics Neutral

Company Net Margins Return on Equity Return on Assets
180 Life SciencesN/A N/A N/A
NeuroSense Therapeutics N/A N/A N/A

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
180 Life SciencesN/AN/AN/AN/AN/A
NeuroSense TherapeuticsN/AN/AN/AN/AN/A

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
180 Life Sciences
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A
NeuroSense Therapeutics
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A

180 Life Sciences and NeuroSense Therapeutics both received 0 outperform votes by MarketBeat users.

CompanyUnderperformOutperform
180 Life SciencesN/AN/A
NeuroSense TherapeuticsN/AN/A

Summary

180 Life Sciences beats NeuroSense Therapeutics on 2 of the 2 factors compared between the two stocks.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

NRSNW vs. The Competition

MetricNeuroSense TherapeuticsBiotechnology IndustryMedical SectorNASDAQ Exchange
Market CapN/A$199.92M$5.17B$7.97B
Dividend YieldN/A3.42%43.86%3.91%
P/E RatioN/A243.81111.5814.17
Price / SalesN/A14,954.302,362.1377.54
Price / CashN/A11.7336.3731.98
Price / BookN/A6.585.744.77
Net IncomeN/A-$19.37M$105.38M$217.01M
7 Day Performance-31.51%0.07%1.85%2.90%
1 Month PerformanceN/A4.77%4.73%6.58%
1 Year Performance-66.20%3.94%7.74%10.15%

NeuroSense Therapeutics Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
ATNFW
180 Life Sciences
0 of 5 stars
$0.01
flat
N/A-58.0%$0.00N/A0.004News Coverage
Positive News
Gap Up
SXTPW
60 Degrees Pharmaceuticals
0 of 5 stars
$0.10
flat
N/AN/A$0.00$253,573.000.002Positive News
Gap Down
DRTSW
Alpha Tau Medical
0 of 5 stars
$0.24
flat
N/A-28.1%$0.00N/A0.00121Short Interest ↓
APLMW
Apollomics
0 of 5 stars
$0.03
flat
N/A-83.9%$0.00N/A0.0059
ARTLW
Artelo Biosciences
0 of 5 stars
$0.01
flat
N/AN/A$0.00N/A0.006News Coverage
Gap Up
BCDAW
BioCardia
0 of 5 stars
$0.02
flat
N/AN/A$0.00$477,000.000.0016
BCTXW
BriaCell Therapeutics
0 of 5 stars
$0.80
-2.4%
N/A-76.7%$0.00N/A0.0016News Coverage
High Trading Volume
CDIOW
Cardio Diagnostics
0 of 5 stars
$0.09
flat
N/A-54.1%$0.00$17,065.000.007
CTCXW
Carmell
0 of 5 stars
$0.10
flat
N/AN/A$0.00$3.73M0.009
SAVAW
Cassava Sciences
0 of 5 stars
$0.03
flat
N/AN/A$0.00N/A0.0029

Related Companies and Tools

This page (NASDAQ:NRSNW) was last updated on 5/18/2024 by MarketBeat.com Staff

From Our Partners